The MotivAir Study to Improve CPAP Adherence in OSAS Patients
MotivAir
The MotivAir Study: a Randomized Controlled Trial of Motivational Interviewing-Based Intervention to Improve Adherence to CPAP in Patients With Obstructive Sleep Apnea Syndrome
1 other identifier
interventional
80
1 country
1
Brief Summary
This study aims to evaluate the effectiveness of the MotivAir program an intervention based on Motivational Interviewing (MI) principles and techniques - in enhancing adherence to Continuous Positive Airway Pressure (CPAP) therapy among patients with Obstructive Sleep Apnea Syndrome (OSAS). Methods. A multicenter randomized controlled trial (RCT) design with random allocation at the level of the individual will be conducted to compare the impact of the experimental program (usual care plus MI) with a control group receiving usual care only in improving selected clinical and psychological parameters in the patients. A minimum sample of 80 participants (40 patients per group) will be recruited in each center according to the inclusion criteria. After the initial screening, participants will be randomly assigned to either the experimental group or the control condition. The program will last 180 days and will be delivered by a trained nurse. The impact of the MotivAir program on selected primary (adherence to CPAP in terms of average hours of usage per night and the Apnea-Hypopnea Index, AHI) and secondary (motivation, perceived competence, quality of life, sleepiness, as well as the emotional state, daily life activities, and quality of the social relationships of the person) outcomes will be measured at baseline, and after 1-, 3-, and 6-month from CPAP initiation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 12, 2022
CompletedStudy Start
First participant enrolled
March 1, 2023
CompletedFirst Posted
Study publicly available on registry
March 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedMarch 22, 2023
March 1, 2023
1 year
May 12, 2022
March 20, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Change from Baseline adherence to CPAP at 6 months
average hours of usage per night
6 months from CPAP initiation
Change from baseline Apnea-Hypopnea Index (AHI) at 6 months
severity of apnea-hypopnea
6 months from CPAP initiation
Secondary Outcomes (3)
Change from baseline Motivation to change at 6 months
6 months from CPAP initiation
Change from baseline of Evaluation of Perceived Competence in Adherence to CPAP in OSAS at 3 and 6 months
6 months from CPAP initiation
Change from Baseline of Visual Analogical Well-being Scale for apnea at 6 months
6 months from CPAP initiation
Study Arms (2)
MotivAir group
EXPERIMENTALSubjects in the MotivAir group will follow an intervention - lasting approximately 45 minutes - based on motivational interviewing principles and techniques delivered by a trained nurse.
Treatment as usual
NO INTERVENTIONParticipants assigned to the control group will receive a usual pulmonary rehabilitation program for patients with OSAS receiving CPAP therapy, which is a standard technical training comprising information regarding the use, maintenance and safety measures of the device, plus a home inspection delivered by a technician who has the only task of doing maintenance to the machinery.
Interventions
During the intervention, the trained-nurse will provide a motivational interviewing-based intervention consisting of one session divided into two parts: educational (the concepts of sleep apnea and the symptoms, and the CPAP treatment will be focused on) and training activity (using MI not directly advocate for behavioral change (i.e., use CPAP as prescribed), but asks key questions to help the patient explore conflicting feelings about the change, weighs the positive consequences and negatives of this change, and allows the patient to realize the discrepancy between current risk behavior (i.e. not using CPAP as directed) and the patient's self-identified goals. The intervention will be tailored on the patient's stage of change based on Prochaska and DiClemente transtheoretical model (1982), in fact, the nurse will use MI not only at the beginning of therapy but also in every contact with the patient throughout the treatment (subsequent follow-up visits, phone calls, etc.).
Eligibility Criteria
You may qualify if:
- having a diagnosis of OSAS confirmed by polysomnography;
- being recommended for treatment with CPAP;
- being naïve to this type of intervention
You may not qualify if:
- use of oxygen therapy \> 2 l/min;
- history of severe cognitive disorders;
- history of COPD: FEV1/FVC (Tiffeneau Index) ≤ 60% with FEV1 ≤ 50%;
- dyspnea on exertion (Borg \> 6);
- diagnosis of Long Covid or Covid-19 infection \< 4 months;
- chronic heart failure (NYHA: Grade III and IV);
- unstable ischemic heart disease;
- inability to understand the consent to participate;
- patient refusal.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
San Giuseppe Hospital, Istituto Auxologico Italiano IRCSS
Verbania, 28921, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gianluca Castelnuovo, PhD
Istututo Auxologico Italiano
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2022
First Posted
March 14, 2023
Study Start
March 1, 2023
Primary Completion
March 1, 2024
Study Completion
December 1, 2024
Last Updated
March 22, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share
Results of the study published in a repository and in an International Journal